Sara Colombetti

5PUBLICATIONS

71CO-AUTHORS

Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 12, 2026

Tobemstomig, a novel bispecific antibody, preferentially blocks PD-1 and LAG-3 on CD8 TILs to expand stem-like T-cells for sustained tumor control.

|Mar 05, 2026

Pathological insights of human CD34+ hematopoietic stem cell-engrafted NSG mice: Implications for the safety assessment of cancer immunotherapy drugs.

Anna Maria Giusti, Johannes Sam, Sara Colombetti

|Aug 01, 2025

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt

|Mar 04, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

|Aug 02, 2022

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

Raffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol

Pageof 1

Frequent Collaborators

Christian Klein

Marina Bacac

Pablo Umaña

Sylvia Herter

Johannes Sam

Stefanie Briner

Samuel Gebhardt

Silvia Jenni

Valeria Nicolini

Carina Hage

Frequent Collaborators

Christian Klein

Marina Bacac

Pablo Umaña

Sylvia Herter